UNSPSC 51131634: Ditazol or ditazole

This classification denotes an antiplatelet agent with the molecular formula C19H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H2BQI5Z8FT, chemically known as 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol but generally known as ditazol, which bears US NIH Compound Identifier 29088. European Medicines Agency schedules Ditazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06328MIG.

The term DITAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules ditazol in its Anatomical Therapeutic Chemical (ATC) Classification. Ditazol or ditazole bears US NLM identifiers UMLS ID C0012777 and NCI Concept Code C65442. SMILES: C1=CC=C(C=C1)C2=C(OC(=N2)N(CCO)CCO)C3=CC=CC=C3.

UNSPSC 51131634 Ditazol or ditazole is a Commodity code with minimal relevant recent state and local procurement activity. The single recent opportunity tagged to this code—Sourcewell RFP #061626 for Law Enforcement Equipment, posted May 12, 2026, with a June 16, 2026 response deadline—does not reflect purchases of ditazol or ditazole but rather broader law enforcement equipment procurement through a cooperative purchasing vehicle. The source contains no evidence of state and local solicitations for this pharmaceutical or chemical product.

The mismatch between the code's nominal scope and the recent opportunity record suggests either a data-tagging error or that ditazol/ditazole procurement does not currently flow through state and local competitive solicitation channels captured in public notice databases. Without additional recent opportunities showing actual demand for this Commodity under the code, the procurement activity remains uncharacterized by issuing body, geographic concentration, or typical contract structure.